Besides botulinum C2 toxin, Clostridium botulinum type C produces another ADP-ribosyltransferase, which we termed 'C3'. ADP-ribosyltransferase C3 has a molecular mass of 25 kDa and modifies 21-24 kDa protein(s) in platelet and brain membranes. C3 was about 1000 times more potent than botulinum Cl toxin in ADP-ribosylation of membrane proteins. C3-catalysed ADP-ribosylation of the 21-24 kDa protein(s) was 
INTRODUCTION
Various microbial toxins affect the eukaryotic cell by ADP-ribosylation of regulatory proteins (Foster & Kinney, 1985) . Well-known examples of this category of toxins are diphtheria, pertussis and cholera toxins. Whereas diphtheria toxin ADP-ribosylates elongation factor II, which modification inhibits protein synthesis (Collier, 1982) , pertussis and cholera toxins affect the regulation of the adenylate cyclase system. Cholera toxin ADP-ribosylates the stimulatory G.-protein of adenylate cyclase (Gill, 1982) , thereby persistently activating the production of cyclic AMP. On the other hand, pertussis toxin modifies the G,-protein (Ui, 1984) and impairs the inhibitory regulation of adenylate cyclase. Furthermore, recent studies have shown that cholera and pertussis toxin not only ADP-ribosylate G-proteins involved in adenylate cyclase regulation, but also modify various proteins belonging to a family of homologous G-proteins (transducin, Go and G), which are involved in different transmembrane signal-transduction processes (Stryer & Bourne, 1986) .
Botulinum C2 toxin, which is produced by certain strains of Clostridium botulinum, is another microbial ADP-ribosyltransferase (Simpson, 1984) . Botulinum C2 toxin ADP-ribosylates isolated actin (Aktories et al., 1986a,b) and actin in intact cells (Reuner et al., 1987) , thereby reducing the ability of the microfilament protein to polymerize (Aktories et al., 1986a) . It has been shown that, in addition to botulinum C2 toxin, certain strains of Clostridium botulinum type C produce a second ADPribosyltransferase, named 'C3', which is clearly distinct from the C2 toxin . The substrate of the novel ADP-ribosyltransferase appears to be 21-24 kDa protein(s) found in various cell types, including platelets, neuroblastoma x glioma hybrid cells, leucocytes and sperm . The nature of the eukaryotic substrate is not known at present. As pertussis, cholera and diphtheria toxins modify GTPbinding proteins (Foster & Kinney, 1985; Collier, 1982; Gill, 1982; Ui, 1984) , we were prompted to investigate whether this was also true for the substrate of the novel ADP-ribosyltransferase C3. It is known that guanine nucleotides modify the properties of G-proteins to serve as substrates of ADP-ribosylating toxins (Kahn & Gilman, 1984; Ui et al., 1985) . Therefore we studied the influence of various guanine nucleotides on the ADPribosylation of the 21-24 kDa protein(s) by C3.
Recently it has been reported that botulinum neurotoxin D and Cl can also ADP-ribosylate an eukaryotic 21 kDa protein. Therefore a further object of the present study was to compare the ADP-ribosyltransferase activities of C3 with those of botulinum neurotoxins.
MATERIALS AND METHODS

Materials
Botulinum ADP-ribosyltransferase C3 was purified from the culture medium of Clostridium botulinum type C strain 486 kindly donated by Dr. M. Sebald, Pasteur Institute, Paris, France, as described by Aktories et al. (1987) . Botulinum C2 toxin was purified as described by Ohishi et al. (1980) . Botulinum Cl toxin was purified from Clostridium botulinum Type C strain C 250, kindly Kurazono et al. (1985) . Clostridium botulinum were cultured essentially as described by Aktories et al. (1987) . All nucleotides used were obtained from Boehringer (Mannheim, Germany). [32P]NAD was prepared as described by Cassel & Pfeuffer (1978) . Preparation and pretreatment of human platelet membranes Human platelet membranes were prepared as described by Aktories & Jakobs (1984) . For pretreatment, 250 ,ul of a suspension of human platelet membranes (1-4 mg of protein/ml) were incubated with 30 ,ul of GTP [S] (100 ,/M) and 20 j1 of triethanolamine/HCl (50 mM, pH 7.5) for 5 min at 37 'C. Thereafter treatment was stopped by the addition of 1 ml of ice-cold triethanolamine/HCl (50 mm, pH 7.5) and centrifugation of the mixture for 4 min at 100000g. The pellet was twice washed with 1 ml of triethanolamine/HCI buffer and finally resuspended in the appropriate volume of 10 mmtriethanolamine/HCl, pH 7.5, for use in the ADPribosylation assay. ADP-ribosylation assay C3-induced ADP-ribosylation of the 21-24 kDa protein(s) in human platelet membranes was performed essentially as described by Aktories et al. (1987) . Briefly, human platelet membranes (50-250 ,ug of protein/tube) were preincubated in a medium containing 10 mmthymidine, 1 mM-MgCl2, 0.5 mM-ATP, 0.1-1 ,sM-[32P]-NAD (about 0.3-1 1sCi/tube) and 50 mM-triethanolamine/HCl, pH 7.5, for 5 min at 37 'C in a total volume of 100 ,1. The reaction was initiated by the addition of C3 ADP-ribosyltransferase and the incubation was continued for further 5 min or as indicated. Determination of the incorporated ADP-ribose was performed by stopping the reaction with 400 ,1 of a solution containing SDS (2 %, w/v) and bovine serum albumin (1 mg/ml) and precipitation of the proteins with 500 ,1 of trichloroacetic acid (30 %, w/v). Proteins were collected on to nitrocellulose filters. The filters were washed ten times with 2 ml of 6 % trichloroacetic acid and placed in scintillation fluid for analysis of retained radioactivity. The filter blank in the absence of botulinum (lanes 2 and 4) or with 100 mM-DTT (lanes 1 and 3) for 10 min at 95 IC and thereafter subjected to SDS/PAGE.
The Mr markers were myosin (Mr 205 000), phosphorylase b (97000), bovine serum albumin (66000), ovalbumin (45000), carbonic anhydrase (29000), trypsinogen (24000), trypsin inhibitor (20000) and a-lactalbumin (14000). (b) ADP-ribosylation of platelet membrane proteins by C3 and botulinum neurotoxin Cl. Human platelet membranes were incubated in the presence of 0.5 ,tM-[32P]NAD with increasing concentrations of C3 (-) or neurotoxin Cl (0) for 30 min. The radioactivity of labelled proteins was determined as described in the Materials and methods section. (c) Autoradiogram of SDS/PAGE of human platelet proteins labelled by C3 or neurotoxin Cl. Human platelet membranes were ADPribosylated by C3 (1.4 ,tg/ml; lane 1) or neurotoxin C1 (7 ,ug/ml; lane 2) as described in the Materials and methods section, with the exception that 10 mM-DTT was present during the incubation. The incubation time was 30 min. Lane 1, exposed for 1 day; lane 2, exposed for 3 days. ADP-ribosyltransferase was 0.1-0.2% of added [32P]-NAD and was subtracted from retained radioactivity. SDS/polyacrylamide-gel electrophoresis After the indicated incubation time the ADP-ribosylation reaction was stopped by the addition of 1 ml of trichloroacetic acid (20 %). The resulted pellet was washed with diethyl ether and dissolved in 50 pAl of electrophoresis buffer and analysed by SDS/PAGE as described by Laemmli (1970) . Gels were stained, destained and subjected to autoradiography. A similar procedure was used for SDS/PAGE analysis of the purified Cl toxin and C3 ADP-ribosyltransferase. Silver staining was performed as described by Wray et al. (1981) .
Protein concentrations were determined by the method of Lowry et al. (1951) , with bovine serum albumin as standard.
RESULTS
Recently we reported the purification of a novel ADPribosyltransferase from Clostridium botulinum culture medium . Fig. 1(a) shows the silverstained SDS/PAGE gel of the ADP-ribosyltransferase C3 purified from Clostridium botulinum type C as described recently . The Mr of C3 was about 25 000 in both the presence and the absence of DTT. The preparation of C3 was apparently free of any higher-Mr contaminants. In particular, there was no indication of contamination by Cl. For comparison, the gel for botulinum neurotoxin Cl is shown on the left of Fig. l(a) . The Mr of the botulinum neurotoxin Cl was about 150000 in the absence of DTT. Under reducing conditions (100 mM-DTT), Cl was cleaved into a light and a heavy chain with Mr 50000 and 100000 respectively. The ADP-ribosylation of 21-24 kDa protein(s) in human platelet membranes by C3 and Cl is shown in Fig. 1(b) . A half-maximal and maximal ADP-ribosylation of the 21-24 kDa protein(s) by C3 was observed at 0.1 and 1-3 ,g respectively. This effect was not increased with DTT (result not shown). In contrast with the extensive ADP-ribosylation caused by C3, botulinum Thereafter the ADP-ribosylation was initiated by the addition of C3 (9 ,g/ml) and [32P]NAD (0.1 M) and the reaction allowed to continue for a further 5 min. The radioactivity of the labelled proteins was determined as described in the text.
neurotoxin Cl caused only marginal labelling, measured by means of the filtration assay. Surprisingly, SDS/ PAGE analysis of the proteins labelled by neurotoxin Cl revealed labelling of 43 and 21-24 kDa proteins (Fig. I c) . ADP-ribosylation of the -21 kDa protein in platelet membranes by Cl was not substantially increased by DTT or trypsin treatment. Influence of guanine nucleotides on the ADPribosylation of the 21-24 kDa substrate protein(s) by botulinum ADP-ribosyltransferase C3 Next we studied the effects of nucleotides on the ADPribosylation of the 21-24 kDa substrate by C3. As shown in Table 1 , GTP[S], but not GTP, GDP or ATP[S], inhibited the ADP-ribosylation by C3. Similar effects of the nucleotides were obtained in the absence or presence of 0.5 mM-ATP and without and with creatine kinase and phosphocreatine (0.4 mg/ml and 5 mm respectively) as a GTP/ATP-regenerating system (results not shown). caused by C3. However, GTP [S] was much more potent and more efficient than the other stable GTP analogues.
In order to study whether GTP[S] acts on C3 or on the protein substrate, platelet membranes were pretreated with 10 1M-GTP[S] for 5 min at 37 'C. Pretreatment was stopped by diluting the incubation mixture with ice-cold buffer, followed by the washing off of unbound GTP [S] . Thereafter the membranes were used for the ADPribosylation assay. As shown in Fig. 4 Fig. 5 , the ADP-ribosylation of the 21-24 kDa protein by C3 was clearly decreased by GTP [S] . In contrast, the labelling by botulinum C2 toxin was not significantly affected by GTP [S] . DISCUSSION Recently, we have shown that a 21 kDa protein in platelet membranes is ADP-ribosylated by a novel ADPribosyltransferase C3 found in the culture medium of Clostridium botulinum . The pathophysiological role of this microbial enzyme is not known at present. Interestingly, it has been reported that botulinum neurotoxins C1 and D also possess ADPribosyltransferase activity , suggesting that the enzymic activity is involved in the neurotoxic effects of these agents. Furthermore, substrates of Cl and D-induced ADPribosylation were also 21 kDa proteins occurred under our experimental conditions. Although it is not possible to decide at present which explanation is correct, one should be cautious in assuming that botulinum neurotoxins are ADP-ribosyltransferases until the purity of the neurotoxin preparations used has been checked.
Ohashi and colleagues reported that the ADP-ribosylation of the 21 kDa protein in brain membranes by botulinum neurotoxins Cl and D was affected by guanine nucleotides. Here we report that guanine nucleotides also influenced the ADP-ribosylation of the 21-24 kDa substrate(s) caused by C3. GTP[S], but not ATP [S] , inhibited the labelling of the 21-24 kDa protein(s) in a concentration-dependent manner, with a maximal inhibitory effect at about 10 /M. This effect was most probably due to a specific reaction of GTP[S] at a GTPbinding protein, since GTP effectively shifted the inhibition curve of GTP[S] to higher nucleotide concentrations. The reason why GTP itself did not inhibit ADP-ribosylation by C3 is not known at present. A nonspecific degradation of GTP is unlikely. Even in the presence of ATP and with a GTP/ATP-regenerating system, which effectively block unspecific GTPase activity (Cassel & Selinger, 1976; Aktories & Jakobs, 1981) , GTP was without any inhibitory effect. (Collier, 1982; Gill, 1982; Ui, 1984; Foster & Kinney, 1985) . These G-proteins are functionally and structurally modified by guanine nucleotides (Stryer & Bourne, 1986) . On the other hand, guanine nucleotides modify the properties of these Gproteins to serve as substrates for ADP-ribosylating toxins. For instance ADP-ribosylation of Gs depends on the presence of GTP (Gill, 1982) , whereas the stable GTP analogue, GTP [S] , inhibits the ADP-ribosylation of Gs and Gi by cholera toxin (Kahn & Gilman, 1984) and pertussis toxin (Ui et al., 1985) respectively. Considering these data, one can speculate also that the substrate of C3 is a GTP-binding protein. Recently several GTPbinding proteins with Mr values of about 21000 have been described. Among these are the various rasoncogene products (Weinberg, 1983; Hagag et al., 1986) , the ADP-ribosylation factor (Kahn & Gilman, 1986 ) and the GTP-binding protein isolated from placenta (Evans et al., 1986) . These proteins, which may be involved in transmembrane signalling, remain to be tested as substrates of C3.
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